These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 6990991)

  • 61. Effects of estrogen therapy on apolipoprotein E in type II hyperlipoproteinemia.
    Falko JM; Schonfeld G; Witztum JL; Kolar J; Weidman SW
    Metabolism; 1979 Nov; 28(11):1171-7. PubMed ID: 226834
    [No Abstract]   [Full Text] [Related]  

  • 62. [Cholesterol and triglyceride content of lipoproteins in hyperlipoproteinemia type II/a, II/b and IV].
    Romics L; Karádi I; Simonyi E
    Orv Hetil; 1980 Oct; 121(43):2629-31. PubMed ID: 7208011
    [No Abstract]   [Full Text] [Related]  

  • 63. Effect of simvastatin on the apparent size of LDL particles in patients with type IIB hyperlipoproteinemia.
    Zhao SP; Hollaar L; van 't Hooft FM; Smelt AH; Gevers Leuven JA; van der Laarse A
    Clin Chim Acta; 1991 Dec; 203(2-3):109-17. PubMed ID: 1777975
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of bezafibrate on the composition of very low density lipoproteins in type IV hyperlipoproteinemia.
    Schwandt P; Weisweiler P; Drosner M; Janetschek P
    Atherosclerosis; 1982 Apr; 42(2-3):245-9. PubMed ID: 7073803
    [No Abstract]   [Full Text] [Related]  

  • 65. [The therapeutic efficacy of bezafibrate in hyperlipoproteinemias of various types].
    Noseda G; Fragiacomo C; Weidmann P; Bachmann C
    Schweiz Med Wochenschr; 1980 Dec; 110(49):1875-7. PubMed ID: 7455660
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Efficacy of ciprofibrate in primary type II and IV hyperlipidemia: the Italian multicenter study.
    Cattin L; Da Col PG; Feruglio FS; Finazzo L; Rimondi S; Descovich G; Manzato E; Zambon S; Crepaldi G; Siepi D
    Clin Ther; 1990; 12(6):482-8. PubMed ID: 2289217
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Lipoprotein composition and lipoprotein interrelations in 50-year-old men with hyperlipoproteinaemia.
    Vessby B; Hedstrand H; Olsson U
    Ups J Med Sci; 1976; 81(2):71-8. PubMed ID: 183321
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of bezafibrate during 4.5 years of treatment of hyperlipoproteinaemia.
    Olsson AG; Lang PD; Vollmar J
    Atherosclerosis; 1985 May; 55(2):195-203. PubMed ID: 4004990
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Conversion of type III hyperlipoproteinaemia to type IV hyperlipoproteinaemia by a fat-free, carbohydrate rich diet.
    Vessby B; Carlson LA
    Eur J Clin Invest; 1975 Jul; 5(4):359-64. PubMed ID: 170119
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The effect of vitamin E on lipoprotein cholesterol distribution.
    Hermann WJ
    Ann N Y Acad Sci; 1982; 393():467-72. PubMed ID: 6959567
    [No Abstract]   [Full Text] [Related]  

  • 71. Relation between RLP-triglyceride to RLP-cholesterol ratio and particle size distribution in RLP-cholesterol profiles by HPLC.
    Okazaki M; Usui S; Tada N; Nakano T; Nakajima K
    Clin Chim Acta; 2000 Jun; 296(1-2):135-49. PubMed ID: 10807977
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The influence of a no-sugar diet on the composition of VLDL-fraction in patients with idiopathic hyperlipoprotenemia of type IIb and IV.
    Cybulska B; Naruszewicz M; Kłosiewicz-Latoszek L; Szostak WB; Chotkowska E
    Mater Med Pol; 1980; 12(4):286-92. PubMed ID: 7266054
    [No Abstract]   [Full Text] [Related]  

  • 73. [Atherosclerosis in familial hypercholesteremia possibly induced by defective HDL].
    Breier C; Lisch HJ; Drexel H; Braunsteiner H
    Schweiz Med Wochenschr; 1984 Mar; 114(9):288-91. PubMed ID: 6710113
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Reduction of high density lipoprotein cholesterol and apoliproprotein A-I concentrations by a lipid-lowering diet.
    Vessby B; Boberg J; Gustafsson IB; Karlström B; Lithell H; Ostlund-Linqvist AM
    Atherosclerosis; 1980 Jan; 35(1):21-7. PubMed ID: 6768372
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Metabolic heterogeneity in very low-density lipoproteins.
    Shepherd J; Packard CJ
    Am Heart J; 1987 Feb; 113(2 Pt 2):503-8. PubMed ID: 3812208
    [No Abstract]   [Full Text] [Related]  

  • 76. Effects of diet on apoprotein E levels and on the apoprotein E subspecies in human plasma lipoproteins.
    Falko JM; Schonfeld G; Witztum JL; Kolar JB; Weidman SW; Steelman R
    J Clin Endocrinol Metab; 1980 Mar; 50(3):521-8. PubMed ID: 7358833
    [No Abstract]   [Full Text] [Related]  

  • 77. [Relation between serum lipoprotein metabolism and biliary lipid metabolism].
    Leiss O; von Bergmann K
    Klin Wochenschr; 1983 Jun; 61(12):579-92. PubMed ID: 6876687
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Long-term effects of a glycosaminoglycan on plasma lipids].
    Avogaro P; Bittolo-Bon G; Alessandrini P
    Clin Ter; 1981 Jul; 98(1):47-61. PubMed ID: 7249572
    [No Abstract]   [Full Text] [Related]  

  • 79. [Gemfibrozil in the treatment of hyperlipoproteinemias].
    Monova D; Petrova V; Belovezhdov N
    Vutr Boles; 1991; 30(2):56-8. PubMed ID: 1891900
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Plasma lipoprotein levels and the prevalence of hyperlipoproteinemia in a Canadian working population.
    Jones GJ; Hewitt D; Godin GJ; Breckenridge WC; Bird J; Mishkel MA; Steiner G; Little JA
    Can Med Assoc J; 1980 Jan; 122(1):37-8, 40-6. PubMed ID: 7363194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.